Purchases and Sales Made in Q3 2022 in A Tyr Pharma Inc (LIFE)
This table provides information about the institutional ownership of A Tyr Pharma Inc (LIFE) during Q3 2022. The information is specifically focused on institutions that hold shares of aTYR PHARMA INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
9.3M+ 664.81% |
$25.9M - $38.6M
|
10.7M
$19.9M
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
407KNew |
$1.14M - $1.69M
|
407K
$757K
|
|
Nov 14, 2022
Q3 2022
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
106K+ 10.94% |
$297K - $442K
|
1.08M
$2.01M
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
48.2K+ 8857.17% |
$134K - $200K
|
48.7K
$90.6K
|
|
Nov 17, 2022
Q3 2022
|
Telemetry Investments, L.L.C.
New York, NY |
BUY
|
- |
45.5K+ 10.18% |
$127K - $189K
|
493K
$916K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
36.7K+ 24.33% |
$102K - $152K
|
188K
$349K
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
21.8K+ 14.75% |
$60.7K - $90.3K
|
169K
$315K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
19.2K+ 87.78% |
$53.4K - $79.5K
|
41K
$76.2K
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
16.5K+ 10.35% |
$46K - $68.5K
|
176K
$327K
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
8.81K+ 156.04% |
$24.6K - $36.6K
|
14.5K
$26.9K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
3.98K+ 198.75% |
$11.1K - $16.5K
|
5.98K
$11.1K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
1.46K+ 0.82% |
$4.07K - $6.05K
|
180K
$335K
|
|
Nov 07, 2022
Q3 2022
|
D.A. Davidson & Co.
|
BUY
|
- |
1K+ 9.26% |
$2.79K - $4.15K
|
11.8K
$21.9K
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
687+ 0.29% |
$1.92K - $2.85K
|
239K
$445K
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
11+ 0.66% |
$30.7 - $45.7
|
1.69K
$3.14K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 10, 2022
Q3 2022
|
Stonepine Capital Management, LLC
Bend, OR |
SELL
|
- |
-600- 0.1% |
$1.67K - $2.49K
|
601K
$1.12M
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-800- 0.43% |
$2.23K - $3.32K
|
183K
$341K
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-997- 2.14% |
$2.78K - $4.14K
|
45.5K
$84.7K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.06K- 1.13% |
$8.53K - $12.7K
|
267K
$497K
|
|
Nov 14, 2022
Q3 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-173K- 46.22% |
$483K - $718K
|
201K
$375K
|